These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 17122632)

  • 21. E-cadherin expression and PSA secretion in human prostate epithelial cells.
    Krill D; Thomas A; Wu SP; Dhir R; Becich MJ
    Urol Res; 2001 Aug; 29(4):287-92. PubMed ID: 11585286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of E-cadherin in primary and metastatic prostate cancer.
    Cheng L; Nagabhushan M; Pretlow TP; Amini SB; Pretlow TG
    Am J Pathol; 1996 May; 148(5):1375-80. PubMed ID: 8623909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. E-cadherin and beta-catenin loss of expression related to bone metastasis in prostate cancer.
    Pontes J; Srougi M; Borra PM; Dall' Oglio MF; Ribeiro-Filho LA; Leite KR
    Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):179-84. PubMed ID: 18685493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells.
    Veveris-Lowe TL; Lawrence MG; Collard RL; Bui L; Herington AC; Nicol DL; Clements JA
    Endocr Relat Cancer; 2005 Sep; 12(3):631-43. PubMed ID: 16172196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expression of cyclooxygenase-2 and vascular endothelial growth factor in human prostate cancer and its significance].
    Jin TX; Li XG; Wu WY; Piao DM; Feng JY; Sang J
    Zhonghua Nan Ke Xue; 2006 Mar; 12(3):207-10. PubMed ID: 16597032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer.
    Umbas R; Isaacs WB; Bringuier PP; Schaafsma HE; Karthaus HF; Oosterhof GO; Debruyne FM; Schalken JA
    Cancer Res; 1994 Jul; 54(14):3929-33. PubMed ID: 7518346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of biochemical recurrence after robot-assisted radical prostatectomy: analysis of 784 Japanese patients.
    Hashimoto T; Yoshioka K; Nagao G; Nakagami Y; Ohno Y; Horiguchi Y; Namiki K; Nakashima J; Tachibana M
    Int J Urol; 2015 Feb; 22(2):188-93. PubMed ID: 25339062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unmethylated E-cadherin gene expression is significantly associated with metastatic human prostate cancer cells in bone.
    Saha B; Kaur P; Tsao-Wei D; Naritoku WY; Groshen S; Datar RH; Jones LW; Imam SA
    Prostate; 2008 Nov; 68(15):1681-8. PubMed ID: 18712716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased immunostaining for macrophage scavenger receptor is associated with poor prognosis of prostate cancer.
    Takayama H; Nonomura N; Nishimura K; Oka D; Shiba M; Nakai Y; Nakayama M; Tsujimura A; Aozasa K; Okuyama A
    BJU Int; 2009 Feb; 103(4):470-4. PubMed ID: 18778349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pan-cadherin as a high level phenotypic biomarker for prostate cancer.
    Wehbi NK; Dugger AL; Bonner RB; Pitha JV; Hurst RE; Hemstreet GP
    J Urol; 2002 May; 167(5):2215-21. PubMed ID: 11956481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COX-2 is overexpressed in primary prostate cancer with metastatic potential and may predict survival. A comparison study between COX-2, TGF-beta, IL-10 and Ki67.
    Richardsen E; Uglehus RD; Due J; Busch C; Busund LT
    Cancer Epidemiol; 2010 Jun; 34(3):316-22. PubMed ID: 20409773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased RECK expression indicating proteolytic imbalance in prostate cancer is associated with higher tumor aggressiveness and risk of prostate-specific antigen relapse after radical prostatectomy.
    Rabien A; Burkhardt M; Jung M; Fritzsche F; Ringsdorf M; Schicktanz H; Loening SA; Kristiansen G; Jung K
    Eur Urol; 2007 May; 51(5):1259-66. PubMed ID: 16806661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical expression of Ki-67 antigen, cox-2 and Bax/Bcl-2 in prostate cancer; prognostic value in biopsies and radical prostatectomy specimens.
    Rubio J; Ramos D; López-Guerrero JA; Iborra I; Collado A; Solsona E; Almenar S; Llombart-Bosch A
    Eur Urol; 2005 Nov; 48(5):745-51. PubMed ID: 16139948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of preoperative factors in localized prostate carcinoma treated with radical prostatectomy: importance of percentage of biopsies that contain tumor and the presence of biopsy perineural invasion.
    Quinn DI; Henshall SM; Brenner PC; Kooner R; Golovsky D; O'Neill GF; Turner JJ; Delprado W; Grygiel JJ; Sutherland RL; Stricker PD
    Cancer; 2003 Apr; 97(8):1884-93. PubMed ID: 12673714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The angiogenic switch for vascular endothelial growth factor-A and cyclooxygenase-2 in prostate carcinoma: correlation with microvessel density, androgen receptor content and Gleason grade.
    Gyftopoulos K; Vourda K; Sakellaropoulos G; Perimenis P; Athanasopoulos A; Papadaki E
    Urol Int; 2011; 87(4):464-9. PubMed ID: 21912077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-cadherin switching occurs in high Gleason grade prostate cancer.
    Jaggi M; Nazemi T; Abrahams NA; Baker JJ; Galich A; Smith LM; Balaji KC
    Prostate; 2006 Feb; 66(2):193-9. PubMed ID: 16173043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relative mRNA expression levels of matrix metalloproteinase to E-cadherin in prostate biopsy specimens distinguishes organ-confined from advanced prostate cancer at radical prostatectomy.
    Kuniyasu H; Ukai R; Johnston D; Troncoso P; Fidler IJ; Pettaway CA
    Clin Cancer Res; 2003 Jun; 9(6):2185-94. PubMed ID: 12796385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low activated leukocyte cell adhesion molecule expression is associated with advanced tumor stage and early prostate-specific antigen relapse in prostate cancer.
    Minner S; Kraetzig F; Tachezy M; Kilic E; Graefen M; Wilczak W; Bokemeyer C; Huland H; Sauter G; Schlomm T
    Hum Pathol; 2011 Dec; 42(12):1946-52. PubMed ID: 21683980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of E-cadherin and beta-catenin proteins in metastatic prostate cancer cells in bone.
    Saha B; Arase A; Imam SS; Tsao-Wei D; Naritoku WY; Groshen S; Jones LW; Imam SA
    Prostate; 2008 Jan; 68(1):78-84. PubMed ID: 18008331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-cadherin increases after androgen deprivation and is associated with metastasis in prostate cancer.
    Jennbacken K; Tesan T; Wang W; Gustavsson H; Damber JE; Welén K
    Endocr Relat Cancer; 2010 Jun; 17(2):469-79. PubMed ID: 20233707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.